Pre-market
⌘K
Sign in Sign up

Insider & Political Trading

Official filings, normalized for faster research
All activity Politicians Insiders
Previous-day view · Mon Sep 14 close. You are previewing the previous trading day. Subscribe to see today live and every other date — plans start at Delta, $39/mo. Sign up Sign in

Desk brief

AI Sep 14

The tape was heavily sell-skewed: 473 filings reported about $154.2M bought versus $745.9M sold, with only one congressional disclosure.

Two insider buying clusters — Cluster buying led the notable signals: four insiders bought roughly $671.5K of PMTS across four filers, while four bought about $992.1K of GPUS across four filers. PMTS GPUS
Multiple insider selling clusters — Selling clusters were broader and larger, including five insiders selling about $18.6M of CHYM, four selling $17.4M of DBX, seven selling $9.2M of COST, three selling $2.1M of IOT, and 11 selling $2.2M of LOGI. CHYM DBX COST IOT LOGI
Cascade added heavily to RSG — Cascade Investment, L.l.c. bought roughly $453.0M of RSG and was also flagged as a 10% owner adding about $453.4M. RSG was the most bought ticker over 14 days at about $695.1M from one filer. RSG L.l.c. Cascade Investment
Largest reported purchase — Over the past 14 days, Bluearc Capital Management, Llc reported the largest purchase at roughly $99.4M of PBLSX. The broader period remained sell-heavy, with about $1.4B bought versus $13.0B sold. PBLSX Llc Bluearc Capital Management

The filings to keep on the tape were the four-filer buying clusters in PMTS and GPUS versus the larger insider selling clusters in CHYM, DBX, COST, IOT, and LOGI. YPF remained the most sold ticker over 14 days at about $5.3B across 22 filers, followed by APGE at about $1.1B across nine filers.

AI-generated from the filings on this page — not financial advice.

Filings · Sep 14
1039

Latest about 11 hours ago

Disclosed buying · 14d
$1.37B

1080 purchases across 1465 tickers

Disclosed selling · 14d
$12.97B

6075 sales and dispositions

Tape lean · 14d
Heavy selling

Largest buy: PBLSX $99.38M

Disclosure flow

Value filed per session · last 60 days

Where the money went

By disclosed value · 14 days · click a bar for the filings
Most bought
Most sold

Signals

Fixed rules over the last 21 days — see each card for why it fired
Cluster selling CHYM
7 insiders sold $209.03M about 11 hours ago
Cluster selling PMTS
9 insiders sold $55.22M about 12 hours ago
Cluster selling DK
9 insiders sold $3.34M about 12 hours ago
Cluster selling ROIV
7 insiders sold $9.26M about 12 hours ago
Cluster selling PCOR
5 insiders sold $8.15M about 13 hours ago
Cluster selling THC
4 insiders sold $37.02M about 13 hours ago
Cluster buying PMTS
5 insiders bought $11.96M about 13 hours ago
$1M+ insider buy PMTS
Tricor Pmt25 Holdings Inc. bought $11.29M about 13 hours ago
10% owner adding PMTS
Tricor Pmt25 Holdings Inc. added $11.29M about 13 hours ago
Executive buy DVN
Gaspar Clay M bought $199.88K about 14 hours ago
Cluster buying GPUS
4 insiders bought $1.14M about 14 hours ago
Cluster selling FIGR
3 insiders sold $20.39M about 14 hours ago

Disclosure sentiment

Who is buying against who is selling · 90 days · −100 to +100
Accumulation
AMR 26 buys · 0 sells +100
AAT 17 buys · 0 sells +100
RCG 52 buys · 0 sells +100
SUJA 22 buys · 0 sells +100
DLHC 43 buys · 0 sells +100
UUU 32 buys · 0 sells +100
Distribution
UTHR 0 buys · 496 sells -100
CRWV 0 buys · 785 sells -100
DELL 0 buys · 651 sells -100
SE 0 buys · 468 sells -100
NET 0 buys · 277 sells -100
STX 0 buys · 240 sells -100

Bullish and bearish sectors

Net disclosed value · 30 days

Buying extends right, selling left. A company in more than one industry counts in each.

631 filings

Filed Transaction Issuer / asset Reporting person Qty / price Value Source
Sep 9, 2026 Same-day filing Disposition Sep 9, 2026
BRNS Barinthus Biotherapeutics Plc.
Share Option (Right to Buy) on Ordinary Shares 		Hooftman Leon Insider Chief Medical Officer 140,000 shares @ $0 Direct ownership $0 SEC Form 4
Disposition Sep 9, 2026 195,166 shares @ $0 Direct ownership $0
Award Sep 9, 2026 Ordinary Shares 361,530 shares Direct ownership Not reported
Disposition Sep 9, 2026 361,530 shares Direct ownership Not reported
Sep 9, 2026 Same-day filing Disposition Sep 9, 2026
BRNS Barinthus Biotherapeutics Plc.
Share Option (Right to Buy) on Ordinary Shares 		Hammacher Alex Insider Director 19,516 shares @ $0 Direct ownership $0 SEC Form 4
Disposition Sep 9, 2026 Ordinary Shares 3,000 shares Direct ownership Not reported
Disposition Sep 9, 2026 Share Option (Right to Buy) on Ordinary Shares 19,197 shares @ $0 Direct ownership $0
Disposition Sep 9, 2026 34,328 shares @ $0 Direct ownership $0
Disposition Sep 9, 2026 20,174 shares @ $0 Direct ownership $0
Disposition Sep 9, 2026 18,604 shares @ $0 Direct ownership $0
Sep 9, 2026 Same-day filing Disposition Sep 9, 2026
BRNS Barinthus Biotherapeutics Plc.
Share Option (Right to Buy) on Ordinary Shares 		Enright William Insider Chief Executive Officer 440,000 shares @ $0 Direct ownership $0 SEC Form 4
Disposition Sep 9, 2026 359,605 shares @ $0 Direct ownership $0
Disposition Sep 9, 2026 176,130 shares @ $0 Direct ownership $0
Disposition Sep 9, 2026 600,000 shares @ $0 Direct ownership $0
Disposition Sep 9, 2026 Ordinary Shares 514,923 shares Indirect ownership Not reported
Disposition Sep 9, 2026 Share Option (Right to Buy) on Ordinary Shares 443,981 shares @ $0 Direct ownership $0
Disposition Sep 9, 2026 Ordinary Shares 728,454 shares Indirect ownership Not reported
Sep 9, 2026 Same-day filing Disposition Sep 9, 2026
BRNS Barinthus Biotherapeutics Plc.
Share Option (Right to Buy) on Ordinary Shares 		Dawes Karen A Insider Director 18,604 shares @ $0 Direct ownership $0 SEC Form 4
Disposition Sep 9, 2026 19,516 shares @ $0 Direct ownership $0
Disposition Sep 9, 2026 34,328 shares @ $0 Direct ownership $0
Disposition Sep 9, 2026 Ordinary Shares 1,700 shares Direct ownership Not reported
Disposition Sep 9, 2026 Share Option (Right to Buy) on Ordinary Shares 19,197 shares @ $0 Direct ownership $0
Disposition Sep 9, 2026 20,174 shares @ $0 Direct ownership $0
Sep 9, 2026 1-day lag Sale Sep 8, 2026
ARTV Artiva Biotherapeutics, Inc.
Common Stock 		Aslan Fred Insider Chief Executive Officer 23,429 shares @ $10.92 Direct ownership $255.75K SEC Form 4
Sep 8, 2026 Same-day filing Award Sep 8, 2026
ARTV Artiva Biotherapeutics, Inc.
Director Stock Option (Right to Buy) on Commo... 		Ra Capital Management, L.p. Insider Director / Ten Percent Owner 13,750 shares @ $0 Indirect ownership $0 SEC Form 4

Showing 76 to 100 of 631 entries